MGX: Metagenomi Inc Financial Statements
Balance sheet, income statement, and cash flow statements for Metagenomi Inc (MGX).
$135.10M Market Cap.
MGX Market Cap. (MRY)
MGX Shares Outstanding (MRY)
MGX Assets (MRY)
Total Assets
$324.60M
Total Liabilities
$89.74M
Total Investments
$224.37M
MGX Income (MRY)
Revenue
$52.30M
Net Income
-$78.06M
Operating Expense
$141.20M
MGX Cash Flow (MRY)
CF Operations
-$109.07M
CF Investing
-$88.16M
CF Financing
$84.01M
MGX Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Total Assets | $324,599,000 (-11.03%) | $364,842,000 (-11.98%) | $414,486,000 (191.91%) | $141,992,000 |
Assets Current | $257,960,000 (-7.30%) | $278,273,000 (-24.16%) | $366,899,000 (236.86%) | $108,916,000 |
Assets Non-Current | $66,639,000 (-23.02%) | $86,569,000 (81.92%) | $47,587,000 (43.87%) | $33,076,000 |
Goodwill & Intangible Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Shareholders Equity | $234,857,000 (273.22%) | -$135,584,000 (-82.17%) | -$74,428,000 (-128.70%) | -$32,544,000 |
Property Plant & Equipment Net | $57,657,000 (-11.51%) | $65,153,000 (95.90%) | $33,258,000 (51.93%) | $21,890,000 |
Cash & Equivalents | $32,634,000 (-77.63%) | $145,851,000 (-23.44%) | $190,514,000 (339.01%) | $43,396,000 |
Accumulated Other Comprehensive Income | $709,000 (830.93%) | -$97,000 (64.60%) | -$274,000 (-1204.76%) | -$21,000 |
Deferred Revenue | $32,999,000 (-58.23%) | $78,994,000 (-28.27%) | $110,127,000 (177.00%) | $39,757,000 |
Total Investments | $224,368,000 (58.84%) | $141,255,000 (-23.85%) | $185,496,000 (146.42%) | $75,275,000 |
Investments Current | $220,921,000 (69.19%) | $130,579,000 (-26.51%) | $177,690,000 (158.05%) | $68,858,000 |
Investments Non-Current | $3,447,000 (-67.71%) | $10,676,000 (36.77%) | $7,806,000 (21.65%) | $6,417,000 |
Inventory | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Trade & Non-Trade Receivables | $1,257,000 (-48.71%) | $2,451,000 (0%) | $0 (0%) | $0 |
Trade & Non-Trade Payables | $533,000 (-70.24%) | $1,791,000 (-10.94%) | $2,011,000 (48.52%) | $1,354,000 |
Accumulated Retained Earnings (Deficit) | -$223,002,000 (-53.85%) | -$144,944,000 (-89.00%) | -$76,689,000 (-131.72%) | -$33,096,000 |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Tax Liabilities | $0 (0%) | $3,266,000 (112.63%) | $1,536,000 (0%) | $0 |
Total Debt | $45,778,000 (-5.08%) | $48,229,000 (159.70%) | $18,571,000 (-62.04%) | $48,928,000 |
Debt Current | $5,592,000 (63.17%) | $3,427,000 (126.20%) | $1,515,000 (120.52%) | $687,000 |
Debt Non-Current | $40,186,000 (-10.30%) | $44,802,000 (162.68%) | $17,056,000 (-64.64%) | $48,241,000 |
Total Liabilities | $89,742,000 (-40.04%) | $149,668,000 (4.80%) | $142,811,000 (45.66%) | $98,041,000 |
Liabilities Current | $37,309,000 (-45.82%) | $68,861,000 (41.87%) | $48,537,000 (92.82%) | $25,172,000 |
Liabilities Non-Current | $52,433,000 (-35.11%) | $80,807,000 (-14.28%) | $94,274,000 (29.37%) | $72,869,000 |
MGX Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Revenues | $52,295,000 (16.84%) | $44,756,000 (160.21%) | $17,200,000 (6978.19%) | $243,000 |
Cost of Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Selling General & Administrative Expense | $32,017,000 (11.00%) | $28,845,000 (54.24%) | $18,701,000 (92.56%) | $9,712,000 |
Research & Development Expense | $109,179,000 (15.65%) | $94,403,000 (118.83%) | $43,139,000 (197.96%) | $14,478,000 |
Operating Expenses | $141,196,000 (14.56%) | $123,248,000 (99.30%) | $61,840,000 (155.64%) | $24,190,000 |
Interest Expense | $0 (0%) | $0 (0%) | $98,000 (-67.55%) | $302,000 |
Income Tax Expense | -$5,513,000 (-168.68%) | $8,027,000 (212.46%) | $2,569,000 (0%) | $0 |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Consolidated Income | -$78,058,000 (-14.36%) | -$68,255,000 (-56.57%) | -$43,593,000 (-103.31%) | -$21,442,000 |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Net Income | -$78,058,000 (-14.36%) | -$68,255,000 (-56.57%) | -$43,593,000 (-103.31%) | -$21,442,000 |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Net Income Common Stock | -$78,058,000 (-14.36%) | -$68,255,000 (-56.57%) | -$43,593,000 (-103.31%) | -$21,442,000 |
Weighted Average Shares | $33,027,889 (870.10%) | $3,404,585 (0.15%) | $3,399,518 (4.34%) | $3,257,987 |
Weighted Average Shares Diluted | $33,027,889 (870.10%) | $3,404,585 (0.15%) | $3,399,518 (4.34%) | $3,257,987 |
Earning Before Interest & Taxes (EBIT) | -$83,571,000 (-38.76%) | -$60,228,000 (-47.16%) | -$40,926,000 (-93.60%) | -$21,140,000 |
Gross Profit | $52,295,000 (16.84%) | $44,756,000 (160.21%) | $17,200,000 (6978.19%) | $243,000 |
Operating Income | -$88,901,000 (-13.26%) | -$78,492,000 (-75.83%) | -$44,640,000 (-86.41%) | -$23,947,000 |
MGX Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Net Cash Flow from Investing | -$88,157,000 (-292.76%) | $45,734,000 (137.43%) | -$122,200,000 (-64.43%) | -$74,316,000 |
Net Cash Flow from Financing | $84,013,000 (8201.68%) | $1,012,000 (-99.58%) | $239,594,000 (500.16%) | $39,922,000 |
Net Cash Flow from Operations | -$109,073,000 (-19.32%) | -$91,409,000 (-407.53%) | $29,724,000 (22.54%) | $24,257,000 |
Net Cash Flow / Change in Cash & Cash Equivalents | -$113,217,000 (-153.49%) | -$44,663,000 (-130.36%) | $147,118,000 (1551.30%) | -$10,137,000 |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Net Cash Flow - Investment Acquisitions and Disposals | -$85,043,000 (-253.10%) | $55,548,000 (151.33%) | -$108,223,000 (-51.55%) | -$71,413,000 |
Capital Expenditure | -$3,114,000 (68.27%) | -$9,814,000 (29.78%) | -$13,977,000 (-381.47%) | -$2,903,000 |
Issuance (Repayment) of Debt Securities | $0 (0%) | $0 (0%) | $0 (0%) | $29,974,000 |
Issuance (Purchase) of Equity Shares | $84,013,000 (2659.03%) | -$3,283,000 (0%) | $0 (0%) | $0 |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Effect of Exchange Rate Changes on Cash | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Share Based Compensation | $16,204,000 (134.09%) | $6,922,000 (252.80%) | $1,962,000 (423.20%) | $375,000 |
Depreciation Amortization & Accretion | $10,051,000 (19.46%) | $8,414,000 (178.15%) | $3,025,000 (128.47%) | $1,324,000 |
MGX Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Gross Margin | 100.00% (0.00%) | 100.00% (0.00%) | 100.00% (0.00%) | 100.00% |
Profit Margin | -149.30% (2.10%) | -152.50% (39.82%) | -253.40% (97.13%) | -8823.90% |
EBITDA Margin | -140.60% (-21.42%) | -115.80% (47.46%) | -220.40% (97.30%) | -8154.70% |
Return on Average Equity (ROAE) | -30.10% (-146.31%) | 65.00% (-20.25%) | 81.50% | - |
Return on Average Assets (ROAA) | -21.00% (-20.00%) | -17.50% (-11.46%) | -15.70% | - |
Return on Sales (ROS) | -159.80% (-18.72%) | -134.60% (43.42%) | -237.90% (97.27%) | -8699.60% |
Return on Invested Capital (ROIC) | -27.20% (11.40%) | -30.70% (-18.53%) | -25.90% | - |
Dividend Yield | 0% | - | - | - |
Price to Earnings Ratio (P/E) | -1.53 | - | - | - |
Price to Sales Ratio (P/S) | 2.28 | - | - | - |
Price to Book Ratio (P/B) | 0.57 | - | - | - |
Debt to Equity Ratio (D/E) | 0.38 (134.60%) | -1.1 (42.47%) | -1.92 (36.31%) | -3.01 |
Earnings Per Share (EPS) | -2.36 (88.23%) | -20.05 (-56.40%) | -12.82 (-94.83%) | -6.58 |
Sales Per Share (SPS) | 1.58 (-87.96%) | 13.15 (159.80%) | 5.06 (6646.67%) | 0.07 |
Free Cash Flow Per Share (FCFPS) | -3.4 (88.57%) | -29.73 (-741.86%) | 4.63 (-29.33%) | 6.55 |
Book Value Per Share (BVPS) | 7.11 (117.86%) | -39.82 (-81.89%) | -21.89 (-119.18%) | -9.99 |
Tangible Assets Book Value Per Share (TABVPS) | 9.83 (-90.83%) | 107.16 (-12.11%) | 121.92 (179.75%) | 43.58 |
Enterprise Value Over EBIT (EV/EBIT) | -2 | - | - | - |
Enterprise Value Over EBITDA (EV/EBITDA) | -2.05 | - | - | - |
Asset Turnover | 0.14 (22.61%) | 0.12 (85.48%) | 0.06 | - |
Current Ratio | 6.91 (71.10%) | 4.04 (-46.54%) | 7.56 (74.69%) | 4.33 |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Free Cash Flow (FCF) | -$112,187,000 (-10.83%) | -$101,223,000 (-742.81%) | $15,747,000 (-26.26%) | $21,354,000 |
Enterprise Value (EV) | $150,808,340 | - | - | - |
Earnings Before Tax (EBT) | -$83,571,000 (-38.76%) | -$60,228,000 (-46.81%) | -$41,024,000 (-91.33%) | -$21,442,000 |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$73,520,000 (-41.89%) | -$51,814,000 (-36.71%) | -$37,901,000 (-91.26%) | -$19,816,000 |
Invested Capital | $300,434,000 (51.46%) | $198,359,000 (2.24%) | $194,006,000 (58.56%) | $122,352,000 |
Working Capital | $220,651,000 (5.37%) | $209,412,000 (-34.22%) | $318,362,000 (280.16%) | $83,744,000 |
Tangible Asset Value | $324,599,000 (-11.03%) | $364,842,000 (-11.98%) | $414,486,000 (191.91%) | $141,992,000 |
Market Capitalization | $135,100,340 | - | - | - |
Average Equity | $258,920,500 (346.58%) | -$105,006,000 (-96.32%) | -$53,486,000 | - |
Average Assets | $371,063,750 (-4.77%) | $389,664,000 (40.05%) | $278,239,000 | - |
Invested Capital Average | $307,090,750 (56.53%) | $196,182,500 (24.03%) | $158,179,000 | - |
Shares | 37,423,917 (19.65%) | 31,277,695 (0.00%) | 31,277,695 | - |